121 related articles for article (PubMed ID: 20708977)
1. Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database.
Tomson T; Lukic S; Ohman I
Epilepsy Behav; 2010 Sep; 19(1):86-8. PubMed ID: 20708977
[TBL] [Abstract][Full Text] [Related]
2. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
Wegner I; Wilhelm AJ; Sander JW; Lindhout D
Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives.
Wegner I; Edelbroek PM; Bulk S; Lindhout D
Neurology; 2009 Oct; 73(17):1388-93. PubMed ID: 19858461
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral contraceptives on lamotrigine levels depends on comedication.
Wegner I; Wilhelm AJ; Lambrechts DA; Sander JW; Lindhout D
Acta Neurol Scand; 2014 Jun; 129(6):393-8. PubMed ID: 24571554
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
Ohman I; Beck O; Vitols S; Tomson T
Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
[TBL] [Abstract][Full Text] [Related]
6. Influence of uridine diphosphate glucuronosyltransferase inducers and inhibitors on the plasma lamotrigine concentration in pediatric patients with refractory epilepsy.
Yamamoto Y; Takahashi Y; Imai K; Ikeda H; Takahashi M; Nakai M; Inoue Y; Kagawa Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):214-20. PubMed ID: 25825021
[TBL] [Abstract][Full Text] [Related]
7. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
Tompson DJ; Ali I; Oliver-Willwong R; Job S; Zhu L; Lemme F; Hammer AE; Vuong A; Messenheimer JA
Epilepsia; 2008 Mar; 49(3):410-7. PubMed ID: 17825077
[TBL] [Abstract][Full Text] [Related]
9. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
10. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
Saetre E; Perucca E; Isojärvi J; Gjerstad L;
Epilepsia; 2007 Jul; 48(7):1292-302. PubMed ID: 17561956
[TBL] [Abstract][Full Text] [Related]
11. Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy.
Contin M; Albani F; Ambrosetto G; Avoni P; Bisulli F; Riva R; Tinuper P; Baruzzi A
Epilepsia; 2006 Sep; 47(9):1573-5. PubMed ID: 16981875
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
13. Seizure frequency in pregnant women treated with lamotrigine monotherapy.
Sabers A; Petrenaite V
Epilepsia; 2009 Sep; 50(9):2163-6. PubMed ID: 19490048
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
[TBL] [Abstract][Full Text] [Related]
15. Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients.
Yamamoto Y; Inoue Y; Matsuda K; Takahashi Y; Kagawa Y
Biol Pharm Bull; 2012; 35(4):487-93. PubMed ID: 22466551
[TBL] [Abstract][Full Text] [Related]
16. Saliva and serum concentration of lamotrigine in patients with epilepsy.
Tsiropoulos I; Kristensen O; Klitgaard NA
Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
[TBL] [Abstract][Full Text] [Related]
17. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.
de Haan GJ; Edelbroek P; Segers J; Engelsman M; Lindhout D; Dévilé-Notschaele M; Augustijn P
Neurology; 2004 Aug; 63(3):571-3. PubMed ID: 15304599
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy with estrogens may reduce lamotrigine serum concentrations: A matched case-control study.
Reimers A
Epilepsia; 2017 Jan; 58(1):e6-e9. PubMed ID: 27805259
[TBL] [Abstract][Full Text] [Related]
19. Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites.
Ohman I; Luef G; Tomson T
Seizure; 2008 Mar; 17(2):199-202. PubMed ID: 18201913
[TBL] [Abstract][Full Text] [Related]
20. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period.
Fotopoulou C; Kretz R; Bauer S; Schefold JC; Schmitz B; Dudenhausen JW; Henrich W
Epilepsy Res; 2009 Jul; 85(1):60-4. PubMed ID: 19272754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
